A new peer-reviewed clinical study has unveiled game-changing results in the field of medical weight loss, thanks to Ivim Health’s IVIM (Individualized Virtual Integrative Medicine) protocol. Patients using the protocol in combination with GLP-1 therapies, like semaglutide, achieved nearly 50% greater weight loss than traditional methods.
Why It Matters
Weight loss isn’t just about prescriptions anymore. Ivim Health’s approach offers a complete care ecosystem — combining expert guidance, functional coaching, app-based tracking, and community support — all delivered virtually.
Key Findings from the Study
- Average 52-week weight loss: 45.9 lbs (19.5%)
- 68-week results: 46.9 lbs (21.8%)
- Nearly half of participants lost more than 20% of their body weight
- Over 99% lost at least 5%
- Low adverse event rate: only 1.7%
- Equal success across branded and compounded GLP-1 therapies
Beyond the Prescription
“This isn’t just about writing a prescription, it’s about rewriting the patient experience,” said Dr. Taylor Kantor, Chief Medical Officer and co-founder of Ivim Health. “We don’t write prescriptions and send patients on their way. From day one, we partner with our patients—delivering compassionate care, ongoing guidance, and surrounding them with a team that actually listens. Our outcomes speak for themselves, but our mission goes even deeper: to restore what healthcare was always meant to be – compassionate, continuous, and centered on each individual’s unique journey.”
Real-Life Transformation
“I’ve lost 100 pounds and regained my health,” shares patient Lindsay Patterson. “It wasn’t just the meds—it was the system, the people, the support.”
